A Guide to Recombinant Nanobody Expression Service

20, Oct. 2026

 

A Guide to Recombinant Nanobody Expression Service

A recombinant nanobody expression service produces a selected nanobody sequence as a purified protein for research, assay development, or other defined applications. It is useful when you already have a candidate sequence and need consistent material for testing; it is different from nanobody discovery, which identifies candidate binders in the first place. For veterinary medicine projects, the right expression plan depends on the intended use, required quantity, format, and quality checks. At NBbiolab, we recommend defining those requirements before requesting a quotation so the proposed scope matches the work you need to do.

Click here to get more.

Key Takeaways

  • Expression services produce protein from a supplied or selected nanobody sequence; they do not automatically establish that the nanobody binds your target or performs in an assay.
  • Specify the veterinary target, application, protein format, quantity, purity needs, and relevant quality tests before comparing suppliers.
  • Ask for a written scope covering expression system, purification, deliverables, lead-time estimate, and any application-specific requirements.
  • Research-use material should not be assumed suitable for animal diagnosis, treatment, or other regulated use without appropriate validation and regulatory review.

Who This Guide Is For

This guide is for veterinary diagnostic developers, animal-health researchers, biotechnology companies, and procurement teams evaluating recombinant nanobody production. It is especially relevant if your team has a nanobody sequence but lacks the equipment or workflow to express and purify it internally. It can also help buyers compare proposals when different suppliers describe their formats or quality controls in different ways.

If you have not identified a candidate sequence, expression alone may not meet your need. In that case, ask whether discovery or screening support is available as a separate project, and confirm how candidate selection connects to the later expression scope. Discovery and production are related but distinct activities, and their timelines, deliverables, and costs should be assessed separately.

What Is Recombinant Nanobody Expression?

A nanobody is a single-domain antibody fragment, commonly based on the variable domain of a camelid heavy-chain-only antibody. A typical VHH domain is approximately 110–130 amino acids long and has an approximate molecular mass of 12–15 kDa, although sequence design and added tags can change the final construct. Recombinant expression uses a host system to produce the protein encoded by the selected sequence.

The service may include sequence review, construct design, expression, purification, and analytical characterization, depending on the supplier’s agreed scope. The resulting material can be supplied in a defined buffer and quantity, with a report describing the work and available test results. These deliverables should be confirmed in writing rather than assumed from the phrase “expression service.”

Expression Is Not the Same as Functional Validation

A purified protein sample is not, by itself, proof of target binding, diagnostic performance, or suitability for use in animals. Binding and functional testing require assays designed around the target and intended application. If those tests are important to your decision, request them explicitly and agree on the assay method and acceptance criteria before the project begins.

Formats, Materials, and Specifications

Buyers can usually discuss an untagged nanobody or a construct carrying a purification or detection tag, such as a His-tag. A fusion format may also be considered when the application calls for a reporter, carrier, or multimeric design, but the added component can affect expression, purification, and assay behavior. Choose the simplest format that supports your experiment, then add complexity only when there is a clear technical reason.

Expression systems may include bacterial, yeast, or mammalian hosts. The appropriate choice depends on sequence behavior, required yield, folding needs, post-translational modifications, and intended use; no one system is automatically best for every nanobody. Ask the supplier to explain the proposed host and what alternatives are available if the initial expression result is not suitable.

Specifications to Define Before Ordering

  • Sequence and construct: Provide the amino acid sequence, any nucleotide sequence available, desired tag, and whether a signal peptide or fusion partner is required.
  • Quantity and concentration: State the amount needed in milligrams and any working concentration or volume constraints. For example, use “1 mg” only as a requested project quantity, not as a universal minimum or standard service package.
  • Purity and identity: Ask which analytical methods will be used and what results will be reported. The appropriate acceptance criteria depend on the application and should be agreed in advance.
  • Buffer and handling: Specify preferred buffer components, storage conditions, and any restrictions related to downstream assays.
  • Endotoxin or other contaminants: For assays or animal-related research, explain the use case and ask whether testing or limits are available. Do not assume a particular endotoxin level unless it is documented in the quotation or report.

Matching the Service to Veterinary Applications

Nanobodies may be investigated as research reagents for veterinary pathogens, animal biomarkers, or assay components. For example, a team developing an in vitro test may need a soluble nanobody that binds a defined antigen, while a research group studying an animal disease may need protein for binding or neutralization experiments. These are project examples, not evidence that any particular nanobody will work against a given target.

For more information, please visit NBbiolab.

Match the protein format and testing plan to the intended workflow. A diagnostic assay may require reproducible binding in the assay’s sample matrix, while a cell-based study may require additional functional testing and careful buffer compatibility. If material could be used in animals or for clinical decision-making, treat that as a separate regulatory and safety question, not an automatic extension of research-grade expression.

How to Select a Supplier

Compare suppliers on scope clarity rather than headline price alone. A useful proposal explains what sequence information is needed, which expression and purification steps are included, what material will be delivered, and which analytical results accompany it. It should also identify exclusions, such as sequence optimization, assay development, or functional validation when those are not part of the package.

Supplier Evaluation Checklist

  1. Confirm that the supplier can review your sequence and discuss construct options before production.
  2. Ask which expression host is proposed and why it fits the molecule and use case.
  3. Request the planned purification approach, deliverable amount, buffer, and available analytical methods.
  4. Clarify whether binding or functional assays are included, optional, or outside the project scope.
  5. Ask for a project-specific lead-time estimate, shipment conditions, and the supplier’s policy if expression or recovery is insufficient.
  6. Confirm confidentiality, sequence ownership, and how project data and samples will be handled.

These questions help separate a basic protein-production quote from a broader service that includes development or validation. They also make supplier responses easier to compare on a like-for-like basis. For a veterinary project, provide the species, target, assay context, and any sample-matrix constraints that could affect downstream testing.

Pricing, Minimum Quantity, and Lead Time

Price and lead time depend on factors such as construct complexity, expression system, requested quantity, purification requirements, analytics, and whether optimization is needed. A supplier may quote a defined package or a project-specific scope, so do not assume that a stated minimum quantity or turnaround applies across all sequences. Ask for the assumptions behind the estimate and whether additional work would require approval and a revised quotation.

To obtain a useful estimate, provide the sequence, target information, intended application, requested quantity, preferred format, and required tests. If you are uncertain about a specification, say so rather than selecting a value without technical justification. A supplier can then identify which choices are essential and which can remain flexible until initial expression results are available.

Working With NBbiolab

At NBbiolab, we approach recombinant nanobody expression as a scoped B2B project: the sequence, intended application, product format, quantity, and quality requirements shape the discussion. Sharing your veterinary research or assay context helps us assess what information is needed to prepare a relevant proposal. If you already have a sequence, include it with your inquiry; if you are still comparing options, outline the target and the result you need from the protein.

For a practical next step, request a quotation that lists the proposed expression and purification scope, deliverable specifications, analytical documentation, estimated lead time, and any exclusions. This makes it easier for your technical and procurement teams to evaluate feasibility before committing. Contact NBbiolab with your project requirements to discuss a recombinant nanobody expression plan suited to your application.

Conclusion

A recombinant nanobody expression service is a fit when you need protein produced from a defined candidate sequence, but the service does not automatically include discovery or prove application performance. The best buying decision starts with a clear use case, a realistic format and quantity, and written agreement on testing and deliverables. For veterinary medicine projects, also distinguish research material from products intended for animal use or clinical decisions. Share your sequence and requirements with NBbiolab to clarify the appropriate scope and request a project-specific quotation.

For more information, please visit Recombinant Nanobody Expression Service.